High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men

Navin Suthahar*, Laura M. G. Meems, Dirk J. van Veldhuisen, Joan E. Walter, Ron T. Gansevoort, Stephane Heymans, Blanche Schroen, Pim van der Harst, Jenny E. Kootstra-Ros, Vanessa van Empel, Christian Mueller, Stephan J. L. Bakker, Rudolf A. de Boer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1158-1168
Number of pages11
JournalMayo Clinic Proceedings
Volume95
Issue number6
DOIs
Publication statusPublished - Jun 2020

Keywords

  • ONSET HEART-FAILURE
  • CARDIAC TROPONIN
  • NATRIURETIC PEPTIDE
  • PROGNOSTIC VALUE
  • ATRIAL-FIBRILLATION
  • SEX-DIFFERENCES
  • FOLLOW-UP
  • RISK
  • MORTALITY
  • EVENTS

Cite this

Suthahar, N., Meems, L. M. G., van Veldhuisen, D. J., Walter, J. E., Gansevoort, R. T., Heymans, S., Schroen, B., van der Harst, P., Kootstra-Ros, J. E., van Empel, V., Mueller, C., Bakker, S. J. L., & de Boer, R. A. (2020). High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men. Mayo Clinic Proceedings, 95(6), 1158-1168. https://doi.org/10.1016/j.mayocp.2020.01.017